Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia
Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia
复制标题
DOI:
10.1179/102453312x13221316477895
复制
发表时间:
2012-03-01
期刊:
影响因子:
1.9
通讯作者:
Li, Yangqiu
中科院分区:
文献类型:
--
作者:
Huang, Le;Chen, Shaohua;Li, Yangqiu
In leukemia patients, T-cell function has been suppressed with the disease progress. Patients with chronic lymphocytic leukemia (CLL) are all to a degree immunodeficient. In order to elucidate the feature of T-cell receptor signal transduction in CLL, the expression levels of CD3 gamma, delta, epsilon, and zeta chain, Fc epsilon RI gamma, and Zap-70 genes in peripheral blood mononuclear cells (PBMCs) were analyzed. Real-time polymerase chain reaction with SYBR Green technique was used for detecting the gene expression level in PBMCs from 13 patients with CLL, 13 healthy individuals, and 10 B-cell acute lymphocytic leukemia (B-ALL) served as control. The beta 2-microglobulin gene was used as an endogenous reference. Relative mRNA expression level of genes was analyzed by using the 2-(Delta Ct) x 100% method. Significant lower expression levels of CD3 gamma, epsilon, and zeta chain genes, as well as Fc epsilon RI gamma gene were found in CLL samples. Moreover, there was lost the negative correlation of the expression levels between CD3 zeta and Fc epsilon RI gamma genes. The expression level of Zap-70 in CLL was lower than those from healthy controls, while higher than those from B-ALL group. There was no significant correlation between the expression levels of CD3 zeta and Zap-70 genes neither in the healthy group nor in the CLL group. In conclusion, the results provide a global gene expression profile of CD3 gamma, delta, epsilon, and zeta chains, and the CD3 zeta-related genes Fc epsilon RI gamma and Zap-70 in CLL. Deficiency of these gene expression levels might represent the feature related to T-cell immunodeficiency. The study might contribute to better understand the cellular immune features in CLL patients.